Canadian CANNAINVESTOR Magazine September 2018 | Page 346

word “weed” in the title rather than “cannabis”.

A recent study appearing in the JAMA Internal Medicine Journal (Click Here) noted how legalizing cannabis in certain American states coincided with a reduction in opiate prescriptions in those states. Being an America study has some benefits because of the established legal cannabis industries that have existed for some time in some states. The study states as its …

Importance: Overprescribing of opioids is considered a major driving force behind the opioid epidemic in the United States. Marijuana is one of the potential nonopioid alternatives that can relieve pain at a relatively lower risk of addiction and virtually no risk of overdose. Marijuana liberalization, including medical and adult-use marijuana laws, has made marijuana available to more Americans.

Meaning: Medical and adult-use marijuana laws have the potential to lower opioid prescribing for Medicaid enrollees, a high-risk population for chronic pain, opioid use disorder, and opioid overdose, and marijuana liberalization may serve as a component of a comprehensive package to tackle the opioid epidemic.

One cannot help but see that the study identifies medical and adult-use. It does not use the word “or” and certainly not recreational adult-use instead of medical.

In 2008, the British Journal of Medicine published the paper Therapeutic potential of cannabis in pain medicine (Click Here) by R. D. Hosking J. P. Zajicek. Part of the findings of this decade old study was that “The strongest evidence of their benefit is for central neuropathic pain in MS. However, CBs [cannabinoids] play a fundamental physiological role in nociception. Advances in cannabis research have ensured a future for these analgesic molecules which have been used since antiquity.” Notice I emphasized the word “evidence”. Notice how it ends noting that we have used cannabinoids since “antiquity” because of an age-old awareness in the treatment of an array of medical conditions.

You may have your opinions as to why the CMA wants an end to the medical cannabis framework in Canada and your reasons may align with their own.

346